CD274 and neoplasm: PD-L1 TPS is the recognised and approved scoring approach in NSCLC but only takes into account tumour cell expression, whilst PD-L1 imaging techniques, including [99mTc]NM-01 SPECT/CT, quantify PD-L1 expression in the entire tumour microenvironment.